Latest Tech News

Stay updated with the latest in technology, AI, cybersecurity, and more

Filtered by: mrna Clear Filter

Moderna CEO Responds to RFK Jr.’s Crusade Against the Covid-19 Vaccine

At the WIRED Health summit on Tuesday, Moderna CEO Stéphane Bancel said the recent changes to Covid-19 vaccine policy made by Health and Human Services secretary Robert F. Kennedy, Jr. are a “step backward.” Moderna is one of the manufacturers of mRNA-based Covid-19 vaccines, and last month the company received approval from the Food and Drug Administration for an updated version of the shot. But as part of that approval, the FDA imposed new restrictions on who can receive the vaccine. Previous

RFK Jr. Cancels Promising Work on Cancer Vaccine

Image by Michael M. Santiago via Getty / Futurism Breakthroughs About 10 weeks before his assassination in 1968, Robert F. Kennedy — better known as Bobby, and the father of our current health secretary, Robert F. Kennedy, Jr. — delivered a rousing address at Vanderbilt University that came to be known as one of his greatest speeches. Quoting his presidential uncle John, who had himself been assassinated less than five years prior, Kennedy told those Vanderbilt students that they were the peop

Launch HN: BlankBio (YC S25) - Making RNA Programmable

Hey HN, we're Phil, Ian and Jonny, and we're building BlankBio ( https://blank.bio ). We're training RNA foundation models to power a computational toolkit for therapeutics. The first application is in mRNA design where our vision is for any biologist to design an effective therapeutic sequence ( https://www.youtube.com/watch?v=ZgI7WJ1SygI ). BlankBio started from our PhD work in this area, which is open-sourced. There’s a model [2] and a benchmark with APIs access [0]. mRNA has the potential

RFK Jr. Is Supporting mRNA Research—Just Not for Vaccines

This month, the US Department of Health and Human Services announced that it was canceling 22 contracts and investments worth nearly $500 million as a part of a “coordinated wind-down” of mRNA vaccine research. Yet some projects that do not involve mRNA or vaccines have been caught up in the purge. At the same time, the administration has quietly endorsed research into mRNA treatments for cancer and genetic disorders. HHS secretary Robert F. Kennedy Jr. has long been suspicious of mRNA vaccines

RFK Jr. defends $500M cut for mRNA vaccines with pseudoscience gobbledygook

If anyone needed a reminder that US health secretary and fervent anti-vaccine advocate Robert F. Kennedy Jr. has no background in science or medicine, look no further than the video he posted on social media Tuesday evening. In the two-and-a-half-minute clip, Kennedy announced that he is canceling nearly $500 million in funding for the development of mRNA-based vaccines against diseases that pose pandemic threats. The funding will be clawed back from 22 now-defunct contracts awarded through the

RFK Jr. Yanks $500 Million From Critical mRNA Vaccine Research

Robert F. Kennedy’s ongoing war against vaccines is escalating. Under his authority, the government has just stripped away its funding toward developing several next-generation vaccines reliant on messenger RNA technology. The U.S. Department of Health and Human Services announced Monday that it is ending its development of mRNA vaccines organized through the Biomedical Advanced Research and Development Authority (BARDA). The revoked funding will affect nearly two dozen projects worth almost $5

HHS Winds Down mRNA Vaccine Development Under BARDA

WASHINGTON, D.C. — The U.S. Department of Health and Human Services (HHS) today announced the beginning of a coordinated wind-down of its mRNA vaccine development activities under the Biomedical Advanced Research and Development Authority (BARDA), including the cancellation and de-scoping of various contracts and solicitations. The decision follows a comprehensive review of mRNA-related investments initiated during the COVID-19 public health emergency. “We reviewed the science, listened to the

Moderna says mRNA flu vaccine sailed through trial, beating standard shot

An mRNA-based seasonal flu vaccine from Moderna was 27 percent more effective at preventing influenza infections than a standard flu shot, the company announced this week. Moderna noted that the new shot, dubbed mRNA-1010, hit the highest efficacy target that it set for the trial, which included nearly 41,000 people aged 50 and above. Participants were randomly assigned to receive either mRNA-1010 or a standard shot and were then followed for about six months during a flu season. Compared to t

Moderna says its mRNA seasonal flu shot is 27% better than current vaccine

An mRNA-based seasonal flu vaccine from Moderna was 27 percent more effective at preventing influenza infections than a standard flu shot, the company announced this week. Moderna noted that the new shot, dubbed mRNA-1010, hit the highest efficacy target that it set for the trial, which included nearly 41,000 people aged 50 and above. Participants were randomly assigned to receive either mRNA-1010 or a standard shot and were then followed for about six months during a flu season. Compared to t